Migraine and irritable bowel syndrome;Migrena a zespół jelita nadwrażliwego

Neurologia i Neurochirurgia Polska

Volumn 39, Issue 4 SUPPL. 1, 2005, Pages

  Mulak, Agata ^a   Paradowski, Leszek ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Brain gut axis; Irritable bowel syndrome; Migraine; Serotonin

Indexed keywords

ANTIMIGRAINE AGENT; ESTROGEN; GRANISETRON; SEROTONIN; SEROTONIN 1B AGONIST; SEROTONIN 1D AGONIST; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; SUMATRIPTAN SUCCINATE;

ABDOMINAL PAIN; ARTICLE; CHRONIC PAIN; DIARRHEA; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; ESTROGEN ACTIVITY; FIBROMYALGIA; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTESTINE INNERVATION; IRRITABLE COLON; MIGRAINE; NAUSEA; NEUROENDOCRINE SYSTEM; NEUROIMMUNOLOGY; PATHOGENESIS; PREVALENCE; PROTEIN FUNCTION; SIDE EFFECT; STRESS; VOMITING;

ABDOMINAL PAIN; DIARRHEA; FEMALE; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIGRAINE DISORDERS; NAUSEA; RECEPTORS, SEROTONIN; SEROTONIN AGENTS; SEX FACTORS; VOMITING;

EID: 24644466427     PISSN: 00283843     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Watson W.C., Sullivan S.N., Corke M. i wsp. Globus and headache: common symptoms of the irritable bowel syndrome. Can Med Assoc J 1978; 18: 387-388.
2. Jones R., Lydeard S. Irritable bowel syndrome in the general population. BMJ 1992; 11: 87-90.
3. Whitehead W.E., Palsson O., Jones K.R. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology 2002; 122: 1140-1156.
4. Farmachidi J.P., Sobesky R., Coffin B. i wsp. Prevalence des troubles fonctionnels digestifs chez des patients migraineux chroniques. Gastroenterol Clin Biol 2002; 26, Suppl. 1: A399.
5. Silberstein S.D. Migraine symptoms: results of a survey of self - reported migraineurs. Headache 1995; 35: 387-396.
6. Yunus M.B. Psychological aspects of fibromyalgia syndrome: a component of the dysfunctional spectrum syndrome. Baillieres Clin Rheumatol 1994; 8: 811-837.
7. Russo E.B. Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment - resistant conditions? Neuroendocrinol Lett 2004; 25: 31-39.
8. Goadsby P.J., Lipton R.B., Ferrari M.D. Migraine - current understanding and treatment. N Engl J Med 2002; 24: 257-270.
9. Warnock J.K., Clayton A.H. Chronic episodic disorders in women. Psychiatr Clin North Am 2003; 26: 725-740.
10. Wood J.D., Alpers D.H., Andrews P.L. Fundamentals of neurogastroenterology: Basic Science. W: Drossman D.A., Corazziari E., Talley N.J. [red.]. Rome II. The Functional Gastrointestinal Disorders: diagnosis, pathophysiology and treatment: a multinational consensus. Wyd. 2. Degon and Associates, McLean 2000: 31-90.
11. Mavromichalis I., Zaramboukas T., Giala M.M. Migraine of gastrointestinal origin. Eur J Pediatr 1995; 154: 406-410.
12. Millichap J.G, Yee M.M. The diet factor in pediatric and adolescent migraine. Pediatr Neurol 2003; 28: 9-15.
13. Shufflebotham J., Hood S., Potokar J. i wsp. Tryptophan depletion study in irritable bowel syndrome (IBS). Gastroenterology 2004; 126, Suppl 2: A372.
14. Mulak A., Bonaz B. Irritable bowel syndrome: a model of the brain-gut interactions. Med Sci Monit 2004; 10: RA55-62.
15. Pata C., Erdal M.E., Derici E. i wsp. Serotonin transporter gene polymorphism in irritable bowel syndrome. Am J Gastroenterol 2002; 97: 1780-1784.
16. Welch K.M. Concepts of migraine headache pathogenesis: insights into mechanisms of chronicity and new drug targets. Neurol Sci 2003; 24, Suppl 2: S149-153.
17. Mertz H., Morgan V., Tanner G. i wsp. Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distension. Gastroenterology 2000; 118: 842-848.
18. Atkinson W., Lockhart S.J., Keevil B.J. i wsp. Platelet depleted plasma 5-hydroxytryptamine (PDP 5-HT) concentration: difference between patients with constipation and diarrhea predominant irritable bowel syndrome. Gastroenterology 2004; 126, Suppl 2: A93.
19. Tack J., Coulie B., Wilmer A. i wsp. Action of the 5-hydroxytryptamine 1 receptor agonist on interdigestive gastrointestinal motility in man. Gut 1998; 42: 36-41.
20. Sifrim D., Holloway R.H., Tack J. i wsp. Effect of sumatriptan, a 5-HT1 agonist, on the frecuency of transient lower esophageal sphincter relaxations and gastroesophageal reflux in healthy subjects. Am J Gastroenterol 1999; 94: 3158-3164.